Related Experiment Video
Updated: Dec 30, 2025

09:03
Extraction of Extracellular Vesicles from Whole Tissue
Published on: February 7, 2019
15.9K
Large extracellular vesicles: Size matters in tumor progression
Chiara Ciardiello1, Rossella Migliorino1, Alessandra Leone1
1Experimental Pharmacology Unit, Istituto Nazionale Tumori Fondazione G. Pascale - IRCCS, Naples, Italy.
Cytokine & Growth Factor Reviews
|January 16, 2020
Summary
Large Oncosomes (LOs), a distinct type of large extracellular vesicle (EV) shed by cancer cells, are highlighted as potential cancer biomarkers. Their unique biogenesis, cargo, and role in cancer progression are discussed.
Area of Science:
- Cell Biology
- Cancer Biology
- Biochemistry
Background:
- Extracellular Vesicles (EVs) are cell-released particles with growing importance in cancer research.
- EVs are involved in intercellular communication and cargo transfer.
- Large EVs (L-EVs) originate from the plasma membrane, distinct from exosomes.
Purpose of the Study:
- To review the biogenesis and release of L-EVs, focusing on Large Oncosomes (LOs).
- To examine the cargo and functional roles of LOs in cancer development and progression.
- To discuss the potential of LOs as cancer biomarkers.
Main Methods:
- Review of literature on L-EV and LO biogenesis.
- Analysis of LO cargo (proteins, nucleic acids).
- Discussion of L-EV internalization mechanisms.
Main Results:
- L-EV biogenesis is influenced by plasma membrane rigidity and cellular signaling.
- Large Oncosomes (LOs) are exclusively shed by cancer cells (1-10 μm).
- LOs carry diverse cargos (proteins, mRNA, miRNA, DNA) impacting cancer progression.
Conclusions:
- LOs represent a promising avenue for cancer diagnostics and prognostics.
- Understanding LO biogenesis and function is crucial for biomarker development.
- Challenges in LO utilization as biomarkers require further investigation.
Related Concept Videos
Overview of Exosomes
3.4K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
3.4K
Intralumenal Vesicles and Multivesicular Bodies
4.6K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
4.6K
The Tumor Microenvironment
7.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.5K
Tumor Progression
7.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K
Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K
Receptor Downregulation in MVBs
2.7K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.7K

